Systemic lupus erythematosus, unspecified

SLE_NOS

systemic lupus erythematosus: An autoimmune multi-organ disease typically associated with vasculopathy and autoantibody production. Most patients have antinuclear antibodies (ANA). The presence of anti-dsDNA or anti-Smith antibodies are highly-specific.

Suggest a new description

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — M32.9 Cause of death: ICD-10 — M32.9 2 out of 7 registries used, show all original rules.	1106
4. Check minimum number of events None	1106
5. Include endpoints None	1106
6. Filter based on genotype QC (FinnGen only)	1106

Control definitions (FinnGen only)

Control exclude: SLE_FG

Extra metadata

First used in FinnGen datafreeze: DF2
Parent code in ICD-10: M32
Name in latin: Lupus erythematosus disseminatus non specificatus

NAME	SLE_NOS
CONTROL_EXCLUDE	SLE_FG
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	M329
HD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	M329
COD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Systemic lupus erythematosus, unspecified based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	1106	939	167
Unadjusted period prevalence (%)	0.28	0.32	0.07
Median age at first event (years)	48.41	47.01	56.26

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
1021: Matched controls
10209

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

M32.9

ICD-10 Finland

Systemic lupus erythematosus, unspecified

4503599627370496.0

323.0

1019

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

39.1

323.0

738

638

P01BA02

ATC

hydroxychloroquine; oral

72.2

323.0

796

477

M32.8

ICD-10 Finland

Other forms of systemic lupus erythematosus

+∞

254.0

233

L04AX01

ATC

azathioprine; systemic

21.5

203.7

313

205

M35.9

ICD-10 Finland

Systemic involvement of connective tissue, unspecified

52.8

195.7

234

M32.1

ICD-10 Finland

Systemic lupus erythematosus with organ or system involvement

+∞

190.7

177

M32.0

ICD-10 Finland

Drug-induced systemic lupus erythematosus

+∞

184.0

171

H02AB06

ATC

prednisolone; systemic

7.2

170.6

805

3474

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

12.8

167.7

325

360

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

5.7

146.4

652

2401

7100A

ICD-9 Finland

Diffuse diseases of connective tissue, Systemic lupus erythematosus

+∞

143.1

134

M32

ICD-10 Finland

Systemic lupus erythematosus

+∞

136.6

128

L04AX03

ATC

methotrexate; systemic (immunosuppressants)

8.8

136.3

329

523

L93.0

ICD-10 Finland

Discoid lupus erythematosus

138.3

136.0

143

L04AA06

ATC

mycophenolic acid; systemic

30.3

122.3

166

M35.0

ICD-10 Finland

Sicca syndrome [Sjögren]

22.0

119.0

178

H02AB07

ATC

prednisone; oral

5.8

104.7

352

847

NK6QA

NOMESCO Finland

Measurement of bone density from tow or more locations with X-ray

8.3

99.1

241

368

M05BA04

ATC

alendronic acid; oral

7.4

92.7

243

412

N08.5*M32.1

ICD-10 Finland

Glomerular disorders in systemic lupus erythematosus

+∞

92.1

GD1AA

NOMESCO Finland

Thorax X-ray examination

3.8

88.0

602

2796

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

7.3

86.4

228

387

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

6.5

82.6

239

459

73410

ICD-8 Finland

Diffuse diseases of connective tissue, Systemic lupus erythematosus

430.1

81.1

M35.1

ICD-10 Finland

Other overlap syndromes

70.2

73.7

R50.9

ICD-10 Finland

Fever, unspecified

4.5

64.3

261

719

L01BA01

ATC

methotrexate; systemic (folic acid analog.)

7.9

57.5

139

200

L88

ICPC

Rheumatoid/seropositive arthritis

7.4

50.8

128

195

C08CA05

ATC

nifedipine; systemic

5.8

47.1

143

279

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.8

46.9

393

1837

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

2.6

45.4

538

3068

M05.8

ICD-10 Finland

Other seropositive rheumatoid arthritis

5.4

44.4

142

294

A02BC02

ATC

pantoprazole; systemic

2.6

42.8

748

5208

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

4.2

41.4

175

483

P01BA01

ATC

chloroquine; systemic

37.4

39.4

H02AB04

ATC

methylprednisolone; systemic

3.1

39.2

250

957

L04AD01

ATC

ciclosporin; systemic

11.0

38.6

H04.10

ICD-10 Finland

Dry eye syndrome

3.6

37.7

187

591

Z01.0

ICD-10 Finland

Examination of eyes and vision

3.1

37.6

238

904

J18.9

ICD-10 Finland

Pneumonia, unspecified

2.9

36.5

266

1107

ZX120

NOMESCO Finland

Intravenous

3.8

36.2

170

512

ND2DA

NOMESCO Finland

Bilateral hand X-ray examination

9.6

35.1

D68.8

ICD-10 Finland

Other specified coagulation defects

17.5

34.9

KA3AT

NOMESCO Finland

Biopsy of kidney with ultrasound guidance

17.5

34.9

C03CA01

ATC

furosemide; systemic

2.6

34.1

301

1399

G05.8*M32.1

ICD-10 Finland

Encephalitis in systemic lupus erythematosus

+∞

33.5

L04AA01

ATC

[U] ciclosporin; systemic

10.5

33.3

L93.1

ICD-10 Finland

Subacute cutaneous lupus erythematosus

337.4

33.1

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

3.0

33.1

216

829

XX9XE

NOMESCO Finland

Other ultrasound examination

14.4

32.9

E0000UV

ATC

2.2

32.6

499

3054

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

3.7

32.1

153

464

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

2.7

31.7

254

1109

G73.7*M32.1

ICD-10 Finland

Myopathy in systemic lupus erythematosus

+∞

30.4

J01FF01

ATC

clindamycin; systemic

2.4

29.7

339

1781

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

3.0

29.0

188

713

N08.5

ICD-10 Finland

Glomerular disorders in systemic connective tissue disorders

154.3

28.8

J01MA12

ATC

levofloxacin; systemic

2.7

28.7

229

987

A49.9

ICD-10 Finland

Bacterial infection, unspecified

3.5

28.4

144

457

Z01.8

ICD-10 Finland

Other specified special examinations

2.4

28.3

283

1385

TPH04

NOMESCO Finland

Cathetrisation of vein

2.5

27.8

258

1209

D07AB08

ATC

desonide; topical

3.0

27.1

174

653

N02AX02

ATC

tramadol; systemic, rectal

2.1

26.9

459

2861

B01AA03

ATC

warfarin; systemic

2.8

26.5

200

829

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

3.2

25.7

146

503

D07AC01

ATC

betamethasone; topical

2.1

23.9

385

2315

J05AB11

ATC

valaciclovir; oral

2.6

23.5

192

832

J99.1*M32.1

ICD-10 Finland

Respiratory disorders in systemic: lupus erythematosus

+∞

23.0

NH3DA

NOMESCO Finland

Bilateral foot X-ray examination

6.0

22.4

111

M13.9

ICD-10 Finland

Arthritis, unspecified

3.5

22.3

112

351

M05BA07

ATC

risedronic acid; oral

5.1

22.2

146

A02BC03

ATC

lansoprazole; oral

2.1

21.9

333

1936

J05AB01

ATC

aciclovir; systemic

2.2

21.7

277

1495

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

4.4

21.7

196

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.9

21.6

458

3025

XF400

NOMESCO Finland

ECG with 12 standard connections

2.5

21.6

184

814

L30.9

ICD-10 Finland

Dermatitis, unspecified

2.3

21.4

224

1102

E000001

ATC

2.2

21.2

264

1408

XPX04

NOMESCO Finland

Angioscopy

28.7

21.0

M79.0

ICD-10 Finland

Rheumatism, unspecified

4.3

21.0

202

R06.0

ICD-10 Finland

Dyspnoea

2.1

20.9

280

1537

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

4.6

20.9

174

SBA10

NOMESCO Finland

Measurement of excretion of saliva

10.1

20.7

D69.6

ICD-10 Finland

Thrombocytopenia, unspecified

7.8

20.0

M05BB03

ATC

alendronic acid and colecalciferol; oral

7.0

19.7

NF1AE

NOMESCO Finland

Hip joint ultrasound examination

5.7

19.6

105

O99.89

ICD-10 Finland

Other specified diseases and conditions complicating pregnancy, childbirth and the puerperium

6.5

19.5

A02BC01

ATC

omeprazole; systemic

2.0

19.4

311

1830

J01FA06

ATC

roxithromycin; oral

1.9

19.3

460

3129

D07AC13

ATC

mometasone; topical

2.0

19.2

328

1977

M34.9

ICD-10 Finland

Systemic sclerosis, unspecified

24.2

18.7

B07.9

ICD-10 Finland

Verruca simplex

4.4

18.5

162

N32.9

ICD-10 Finland

Bladder disorder, unspecified

25.6

18.3

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

2.6

18.2

148

634

B01AB05

ATC

enoxaparin; parenteral

1.9

18.1

329

2019

J01MA02

ATC

ciprofloxacin; systemic

1.9

18.0

399

2627

XCW99

NOMESCO Finland

Other investigative procedure of eye

2.7

18.0

134

547

NF1AA

NOMESCO Finland

Hip X-ray examination

3.0

17.9

111

403

A02BC05

ATC

esomeprazole; systemic

1.8

17.8

438

2986

D69.3

ICD-10 Finland

Idiopathic thrombocytopenic purpura

14.9

17.7

L99

ICPC

Musculoskeletal disease other

6.3

17.6

73491

ICD-8 Finland

Diffuse diseases of connective tissue, Collagenosis NUD

182.9

17.6

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.8

17.5

122

478

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

3.5

17.4

250

1XC02

NOMESCO Finland

12.8

17.2

R59.0

ICD-10 Finland

Localized enlarged lymph nodes

5.1

17.1

110

I73.0

ICD-10 Finland

Raynaud syndrome

6.8

17.0

M25.5

ICD-10 Finland

Pain in joint

1.9

17.0

331

2074

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

5.2

16.9

107

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

2.9

16.9

110

413

D70.89

ICD-10 Finland

Neutropenic splenomegaly

9.5

16.7

C08CA01

ATC

amlodipine; oral

1.9

16.7

324

2026

L93.2

ICD-10 Finland

Other local lupus erythematosus

172.6

16.5

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

5.5

16.5

XW000

NOMESCO Finland

Bone marrow biopsy

4.1

16.4

167

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

2.2

16.4

195

1004

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.9

16.3

103

379

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

3.3

16.3

280

J01DB01

ATC

cefalexin; oral

2.0

16.2

850

7295

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

3.7

16.2

210

L01AA01

ATC

cyclophosphamide; systemic

17.0

16.1

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

3.1

15.8

315

D64.9

ICD-10 Finland

Anaemia, unspecified

2.8

15.7

108

419

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

2.3

15.7

152

709

R4110

NOMESCO Finland

Physiotherapy

1.9

15.6

292

1793

M35.8

ICD-10 Finland

Other specified systemic involvement of connective tissue

38.7

15.4

N03AX16

ATC

pregabalin; oral

1.9

15.3

266

1588

M81.9

ICD-10 Finland

Osteoporosis, unspecified

3.8

15.3

178

N03AX12

ATC

gabapentin; oral

2.2

15.3

180

922

R51.80

ICD-10 Finland

Headache

2.1

15.2

182

939

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

3.9

15.2

174

R07.4

ICD-10 Finland

Chest pain, unspecified

1.9

15.1

274

1662

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

2.1

15.1

192

1015

M05BX04

ATC

denosumab; parenteral

3.4

15.1

234

R4120

NOMESCO Finland

Occupational therapy

3.0

14.9

315

M80.4

ICD-10 Finland

Drug-induced osteoporosis with pathological fracture

16.8

14.8

H26.3

ICD-10 Finland

Drug-induced cataract

10.6

14.8

B02.9

ICD-10 Finland

Zoster without complication

3.1

14.7

283

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

2.8

14.7

374

D07AB02

ATC

hydrocortisone butyrate; topical

1.8

14.7

315

2023

UJF30

NOMESCO Finland

Ileoscopy through colon

2.5

14.6

125

547

L93

ICD-10 Finland

Lupus erythematosus

+∞

14.6

G73.7

ICD-10 Finland

Myopathy in other diseases classified elsewhere

+∞

14.6

WZA10

NOMESCO Finland

Long statement of health and health related matters

6.9

14.6

M06.9

ICD-10 Finland

Rheumatoid arthritis, unspecified

4.3

14.5

131

A46

ICD-10 Finland

Erysipelas

2.4

14.5

137

630

L98.9

ICD-10 Finland

Disorder of skin and subcutaneous tissue, unspecified

6.5

14.4

L04AA13

ATC

leflunomide; oral

4.5

14.3

119

318

Kela drug reimbursment

Teriparatide

13.6

14.2

N02BE01

ATC

paracetamol; systemic, rectal

2.0

14.2

881

7758

NH3EA

NOMESCO Finland

Feet X-ray examination with load

5.5

14.0

UGC12

NOMESCO Finland

Flexible bronchoscopy

2.9

13.8

301

I15.1

ICD-10 Finland

Hypertension secondary to other renal disorders

8.7

13.8

SAA03

NOMESCO Finland

Extended examination of mouth

1.7

13.8

415

2939

A07AA02

ATC

nystatin; oral

2.9

13.7

320

R70.0

ICD-10 Finland

Elevated erythrocyte sedimentation rate

5.8

13.7

C08CA02

ATC

felodipine; oral

2.7

13.7

387

J01DA01

ATC

[U] cefalexin; systemic

1.7

13.6

660

5329

D07AD01

ATC

clobetasol; topical

2.0

13.5

183

991

B99

ICD-10 Finland

Other and unspecified infectious diseases

6.5

13.3

L95

ICPC

Osteoporosis

4.1

13.3

133

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.7

13.2

389

2730

R21

ICD-10 Finland

Rash and other nonspecific skin eruption

3.3

13.2

207

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

2.7

13.2

377

M05BA01

ATC

etidronic acid; systemic

12.3

13.1

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

3.7

13.1

165

SPAT1148

SPAT

Treatment of chronic ulcer or burn

2.2

13.0

135

651

M81.4

ICD-10 Finland

Drug-induced osteoporosis

17.0

13.0

I30.9

ICD-10 Finland

Acute pericarditis, unspecified

17.0

13.0

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

2.9

12.9

279

XQ848

NOMESCO Finland

Dermatological photography

5.0

12.7

WX002

NOMESCO Finland

Sedation and analgesia

1.9

12.7

202

1161

L27.0

ICD-10 Finland

Generalized skin eruption due to drugs and medicaments

7.2

12.6

D59.1

ICD-10 Finland

Other autoimmune haemolytic anaemias

32.4

12.6

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.2

12.6

134

654

M79.7

ICD-10 Finland

Fibromyalgia

3.4

12.6

193

69540

ICD-8 Finland

Erythematous condition, Lupus erythematosus

+∞

12.5

I32.8*M32.1

ICD-10 Finland

Pericarditis (in) systemic lupus erythematosus

+∞

12.5

M05BA06

ATC

ibandronic acid; systemic

4.9

12.5

WZC05

NOMESCO Finland

Specialty-specific consultation based on referral by dentist or doctor

3.1

12.5

244

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

4.7

12.5

N06AA09

ATC

amitriptyline; systemic

2.3

12.4

124

586

EP1AE

NOMESCO Finland

Neck ultrasound examination

2.9

12.4

281

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.6

12.3

464

3461

N02AA05

ATC

oxycodone; systemic

2.2

12.2

136

676

NH3BA

NOMESCO Finland

Foot and toes extensive X-ray examination

3.5

12.2

170

TNX00

NOMESCO Finland

Puncture and needle biopsy of soft tissue, unspecified region

5.0

12.1

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

3.3

12.1

193

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.7

12.0

345

2387

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.7

11.9

311

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.9

11.9

189

1082

J01AA02

ATC

doxycycline; systemic

1.7

11.8

790

6813

WX110

NOMESCO Finland

Local anesthesy

1.6

11.8

698

5821

UJF32

NOMESCO Finland

Coloscopy

1.8

11.8

253

1603

SHA02

NOMESCO Finland

Correction of physiology of bite - basic therapy visit

2.5

11.7

379

J01MA14

ATC

moxifloxacin; systemic

2.4

11.7

102

451

NH3AE

NOMESCO Finland

Feet ultrasound examination

30.4

11.7

A02BA02

ATC

ranitidine; systemic

1.9

11.6

202

1195

KA1AE

NOMESCO Finland

Kidney ultrasound examination

5.1

11.6

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

5.1

11.6

QC6S1

NOMESCO Finland

Photography of skin or subcutaneous tissue in hand

23.2

11.6

NH1AE

NOMESCO Finland

Ankle joint ultrasound examination

11.3

11.6

G73.7*M35.0

ICD-10 Finland

Myopathy in sicca syndrome [Sjögren]

121.3

11.4

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

2.9

11.4

242

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

2.1

11.4

130

651

TND11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in joint, wrist or hand

5.9

11.4

TNH11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in ankle joint or foot joint

7.1

11.4

XF404

NOMESCO Finland

Ambulatory ECG

2.4

11.3

427

O99.1

ICD-10 Finland

Other diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism complicating pregnancy, childbirth and the puerperium

9.0

11.3

J02AC01

ATC

fluconazole; systemic

1.6

11.2

485

3716

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

4.1

11.2

109

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

4.0

11.2

114

S81.8

ICD-10 Finland

Open wound of other parts of lower leg

3.9

11.2

119

TAB00

NOMESCO Finland

Lumbar puncture

3.1

11.1

200

H05AA02

ATC

teriparatide; parenteral

12.1

10.9

J84.9

ICD-10 Finland

Interstitial pulmonary disease, unspecified

6.6

10.8

SPAT1263

SPAT

Sampling

1.6

10.8

431

3228

M01AE03

ATC

ketoprofen; systemic, rectal

1.6

10.8

366

2630

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.1

10.8

128

652

M01AH02

ATC

rofecoxib; oral

2.0

10.8

146

788

N02AJ06

ATC

codeine and paracetamol; systemic

1.6

10.7

369

2661

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

2.3

10.7

100

458

7109X

ICD-9 Finland

Diffuse diseases of connective tissue, Unspecified diffuse connective tissue disease

60.6

10.6

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.2

10.6

114

557

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

2.1

10.5

132

689

F02.89*M32.8

ICD-10 Finland

Dementia in systemic lupus erythematosus

+∞

10.4

N16.4*M32.1

ICD-10 Finland

Renal tubulo-interstitial disorders in systemic lupus erythematosus

+∞

10.4

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

2.4

10.4

416

K90.0

ICD-10 Finland

Coeliac disease

3.6

10.3

133

S97

ICPC

Chronic ulcer skin

3.0

10.3

205

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.6

10.2

457

3503

SPAT1149

SPAT

Suture or treatment of traumatic wound

2.1

10.2

122

624

L84

ICD-10 Finland

Corns and callosities

3.5

10.2

140

D02BB01

ATC

betacarotene; oral

13.3

10.2

R05

ICD-10 Finland

Cough

1.8

10.2

199

1218

I31.9

ICD-10 Finland

Disease of pericardium, unspecified

9.2

10.0

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.6

10.0

302

2094

ULA02

NOMESCO Finland

Kolposcopy

2.0

10.0

138

750

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

5.0

10.0

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.6

9.9

278

1891

M01AE02

ATC

naproxen; oral, rectal

1.5

9.9

576

4678

ZX140

NOMESCO Finland

Intra articular

7.1

9.8

M31.1

ICD-10 Finland

Thrombotic microangiopathy

26.3

9.8

P01AB01

ATC

metronidazole; oral, rectal

1.5

9.8

420

3180

GD1AD

NOMESCO Finland

Thorax CT examination

3.3

9.8

145

R06AE07

ATC

cetirizine; oral

1.5

9.7

464

3598

ZXA00

NOMESCO Finland

Right side

1.7

9.7

257

1720

M79.6

ICD-10 Finland

Pain in limb

1.6

9.7

361

2641

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

2.2

9.7

103

502

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

3.2

9.6

163

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

5.0

9.6

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.9

9.6

162

942

WZC10

NOMESCO Finland

Extensive specialist consultion with written report

2.8

9.5

229

WW200

NOMESCO Finland

Immunization

3.6

9.5

116

S76

ICPC

Skin infection other

2.9

9.5

206

Z96.1

ICD-10 Finland

Presence of intraocular lens

2.1

9.4

110

556

D07AA02

ATC

hydrocortisone; topical

1.9

9.4

148

841

XG470

NOMESCO Finland

Measurement of diffusion capastity of the lungs

3.8

9.4

102

M31.9

ICD-10 Finland

Necrotizing vasculopathy, unspecified

21.9

9.4

L95.9

ICD-10 Finland

Vasculitis limited to skin, unspecified

21.9

9.4

G40.9

ICD-10 Finland

Epilepsy, unspecified

3.5

9.3

123

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.4

9.3

346

NB1AE

NOMESCO Finland

Shoulder ultrasound examination

4.6

9.3

M35.3

ICD-10 Finland

Polymyalgia rheumatica

3.3

9.3

140

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

5.3

9.3

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

4.7

9.3

A07EC01

ATC

sulfasalazine; oral, rectal

2.2

9.3

463

L28

ICPC

Limited function/disability (L)

1.9

9.2

152

878

I50.9

ICD-10 Finland

Heart failure, unspecified

2.2

9.2

456

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

2.9

9.2

192

XA800

NOMESCO Finland

Neuropsychological investigation

3.0

9.2

179

TEA00

NOMESCO Finland

Biopsy of lip

7.8

9.2

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

2.3

9.1

376

JN4BD

NOMESCO Finland

Extensive body CT

2.1

9.1

104

524

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

2.5

9.1

286

PAW37

NOMESCO Finland

Biopsy of temporal artery

11.6

9.1

N03AF02

ATC

oxcarbazepine; oral

3.5

9.1

121

EBA10

NOMESCO Finland

Surgical removal of tooth

2.0

9.0

118

627

L01BB01

ATC

15.7

9.0

WX320

NOMESCO Finland

Spinalanesthesy

1.7

9.0

221

1445

SAA04

NOMESCO Finland

Special inverstigation of mouth

2.6

9.0

272

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

2.5

9.0

281

J84.1

ICD-10 Finland

Other interstitial pulmonary diseases with fibrosis

6.6

9.0

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

2.4

9.0

332

TNG10

NOMESCO Finland

Puncture of knee

5.3

8.9

D01AE16

ATC

amorolfine; topical

2.0

8.9

115

608

313

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)

3.4

8.9

128

H20.0

ICD-10 Finland

Acute and subacute iridocyclitis

2.9

8.9

184

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)

1.6

8.8

312

2242

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

2.4

8.8

308

5BA08

NOMESCO Finland

10.8

8.8

ND2BA

NOMESCO Finland

Hand and fingers extensive X-ray examination

4.1

8.8

M13.0

ICD-10 Finland

Polyarthritis, unspecified

6.0

8.8

A11CC03

ATC

alfacalcidol; systemic

4.4

8.8

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

4.4

8.8

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

2.7

8.7

228

A01

ICPC

Pain general/multiple sites

2.2

8.7

410

XG410

NOMESCO Finland

Flow-volume spirometry

3.0

8.7

175

B03XA02

ATC

darbepoetin alfa; parenteral

5.1

8.7

R13

ICD-10 Finland

Dysphagia

2.5

8.7

293

E000007

ATC

2.4

8.7

304

H02AB09

ATC

hydrocortisone; systemic

4.0

8.6

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

2.5

8.6

276

K11.2

ICD-10 Finland

Sialoadenitis

3.1

8.6

149

L17

ICPC

Foot/toe symptom/complaint

1.6

8.5

243

1652

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

3.2

8.5

133

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.6

8.5

237

1604

J84.8

ICD-10 Finland

Other specified interstitial pulmonary diseases

5.7

8.5

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

2.6

8.5

227

K07.60

ICD-10 Finland

Snapping jaw

2.5

8.4

283

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.9

8.4

119

651

7100A

ICD-10 Finland

+∞

8.3

M34.1

ICD-10 Finland

CR(E)ST syndrome

10.8

8.3

AA1AD

NOMESCO Finland

CT of head and brain

1.7

8.3

202

1316

A63.0

ICD-10 Finland

Anogenital (venereal) warts

2.7

8.3

206

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

2.0

8.2

108

575

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

3.0

8.2

163

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

2.7

8.2

207

X58

ICD-10 Finland

Exposure to other specified factors

1.9

8.2

126

709

D06BX01

ATC

metronidazole; topical

1.9

8.2

119

659

NE1AA

NOMESCO Finland

Pelvis X-ray examination

2.5

8.2

264

CK2S4

NOMESCO Finland

Plain photography of ocular fundus

2.5

8.1

275

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

2.2

8.1

383

L71.8

ICD-10 Finland

Other rosacea

4.9

8.1

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.9

8.1

116

637

C07AB07

ATC

bisoprolol; oral

1.5

8.1

392

3012

R76.0

ICD-10 Finland

Raised antibody titre

11.8

8.1

R03AC02

ATC

salbutamol; inhalant

1.5

8.1

518

4215

XCK00

NOMESCO Finland

Perimetry

2.3

8.0

310

N04.9

ICD-10 Finland

Nephrotic syndrome, unspecified

22.2

8.0

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

2.8

8.0

191

S01AA01

ATC

chloramphenicol; ophthalmic (antibiotics)

2.5

8.0

252

TGC00

NOMESCO Finland

Bronchial lavation

3.8

8.0

SHB00

NOMESCO Finland

Prepation and fitting of bite rail to mouth

1.9

8.0

117

647

A41.9

ICD-10 Finland

Sepsis, unspecified

3.4

8.0

107

SPAT1325

SPAT

Vaccination

1.5

8.0

305

2223

I34.09

ICD-10 Finland

Mitral (valve) insufficiency

3.3

7.9

118

XCH00

NOMESCO Finland

Eye pressure measurement

3.1

7.9

141

ZX108

NOMESCO Finland

Inhalation

7.8

7.9

Z49.1

ICD-10 Finland

Extracorporeal dialysis

5.8

7.8

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.8

7.8

142

847

NA1EA

NOMESCO Finland

Cervical spine X-ray examination with flexion

4.9

7.8

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

2.7

7.8

206

E000002

ATC

1.9

7.8

123

702

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.8

7.8

150

914

J31.0

ICD-10 Finland

Chronic rhinitis

2.1

7.7

420

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.5

7.7

268

1908

R87.6

ICD-10 Finland

Abnormal findings in specimens from female genital organs, abnormal cytological findings

1.8

7.7

128

742

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.6

7.7

225

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

2.4

7.7

283

H53.1

ICD-10 Finland

Subjective visual disturbances

2.3

7.7

313

ZXA05

NOMESCO Finland

Left side

1.6

7.7

234

1615

B01AB04

ATC

dalteparin; parenteral

2.5

7.6

235

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.7

7.6

155

954

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.6

7.6

223

1522

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

3.3

7.6

111

ZZH31

NOMESCO Finland

Bone allograft, small pieces

8.1

7.6

M33.9

ICD-10 Finland

Dermatopolymyositis, unspecified

25.2

7.6

XLD00

NOMESCO Finland

Sytologyspecimen from mouth of uterus

1.7

7.6

151

925

M02.9

ICD-10 Finland

Reactive arthropathy, unspecified

4.3

7.5

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.8

7.5

136

808

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.8

7.5

136

809

Z71.8

ICD-10 Finland

Other specified counselling

1.6

7.5

239

1665

A01AB04

ATC

amphotericin B; local oral

2.4

7.5

262

NH1CG

NOMESCO Finland

Ankle and foot extensive MRI examination with high intensity magnet

4.5

7.5

N30.0

ICD-10 Finland

Acute cystitis

1.7

7.5

155

961

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

1.9

7.5

111

617

A01AB10

ATC

natamycin; local oral

3.1

7.4

130

6489X

ICD-9 Finland

Other current conditions in the mother classifiable elsewhere but complicating pregnancy, childbirth and the puerperium, Other current conditions classifiable elsewhere

10.9

7.3

RJ421

NOMESCO Finland

10.9

7.3

4AA26

NOMESCO Finland

+∞

7.3

C09AA02

ATC

enalapril; systemic

1.7

7.3

155

969

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

2.2

7.3

360

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.6

7.3

216

1478

SPA00

NOMESCO Finland

Changing form of teeth in prepation for prothetic work

2.6

7.3

196

NDB78

NOMESCO Finland

Prosthetic replacement of several of finger or metacarpal

15.8

7.2

281

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab

3.2

7.2

116

M06.0

ICD-10 Finland

Seronegative rheumatoid arthritis

3.0

7.2

133

SHA03

NOMESCO Finland

Correction of physiology of bite - demanding therapy visit

2.8

7.2

156

XF655

NOMESCO Finland

Measurement of heart muscle perfusion with exercise

3.6

7.2

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.8

7.2

130

773

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

4.0

7.2

J01MA06

ATC

norfloxacin; oral

1.7

7.2

148

917

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.5

7.2

388

3028

D02AX

ATC

Other emollients and protectives

2.7

7.2

174

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

2.1

7.1

421

L71.9

ICD-10 Finland

Rosacea, unspecified

3.3

7.1

101

N29

ICPC

Neurological sympt/complt other

4.6

7.1

Z35.8

ICD-10 Finland

Supervision of other high-risk pregnancies

1.9

7.1

101

555

6BA02

NOMESCO Finland

12.1

7.1

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

2.0

7.1

424

M80.9

ICD-10 Finland

Unspecified osteoporosis with pathological fracture

4.8

7.0

A28

ICPC

Limited function/disability NOS

1.8

7.0

115

664

LCA06

NOMESCO Finland

Biopsy of endometrium

1.7

7.0

146

907

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.8

7.0

123

724

A02BA04

ATC

nizatidine; systemic

2.1

7.0

405

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

2.0

7.0

491

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

3.5

6.9

WX892

NOMESCO Finland

Monitored bed care

2.2

6.9

310

S01AX11

ATC

[U] ofloxacin; ophthalmic

3.0

6.9

135

A12AA04

ATC

calcium carbonate; oral

4.8

6.9

GD1CD

NOMESCO Finland

Thorax extensive CT-examination

6.7

6.8

WZA90

NOMESCO Finland

Other doctors statement

1.6

6.8

221

1543

XFE00

NOMESCO Finland

Epicardial ultrasonography

3.7

6.8

A01AC01

ATC

triamcinolone; local oral

3.9

6.8

J99.1

ICD-10 Finland

Respiratory disorders in other diffuse connective tissue disorders

40.3

6.8

A12BA01

ATC

potassium chloride; oral

2.7

6.7

169

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

7.2

6.7

N08.5*M31.3

ICD-10 Finland

Glomerular disorders in Wegener's granulomatosis

22.7

6.7

RJ412

NOMESCO Finland

22.7

6.7

L94.8

ICD-10 Finland

Other specified localized connective tissue disorders

22.7

6.7

M54.5

ICD-10 Finland

Low back pain

1.5

6.7

316

2394

K07.65

ICD-10 Finland

Temporomandibular joint-pain-dysfunction syndrome

5.2

6.6

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

5.9

6.6

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.6

6.6

208

1441

B01AF01

ATC

rivaroxaban; oral

1.9

6.6

507

TK800

NOMESCO Finland

Hemodialysis

3.9

6.6

RJ511

NOMESCO Finland

12.3

6.6

N05CF01

ATC

zopiclone; oral

1.5

6.6

299

2246

H26.2

ICD-10 Finland

Complicated cataract

4.8

6.5

K73.2

ICD-10 Finland

Chronic active hepatitis, not elsewhere classified

10.1

6.5

QBA99

NOMESCO Finland

Other local destruction of skin of trunk

6.9

6.5

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.9

6.5

100

564

Z94.0

ICD-10 Finland

Kidney transplant status

5.1

6.5

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

2.2

6.5

309

H10.0

ICD-10 Finland

Mucopurulent conjunctivitis

2.1

6.5

332

LEB30

NOMESCO Finland

Destruction of lesion of vaginal mucosa

6.2

6.5

D02AE01

ATC

carbamide; topical

2.1

6.5

360

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

2.1

6.5

347

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.7

6.5

130

800

M31.8

ICD-10 Finland

Other specified necrotizing vasculopathies

70.2

6.4

7108X

ICD-9 Finland

Diffuse diseases of connective tissue, Other specified diffuse diseases of connective tissue

70.2

6.4

E000004

ATC

3.6

6.4

R80

ICD-10 Finland

Isolated proteinuria

7.5

6.4

127

Kela drug reimbursment

Transplant complication

4.1

6.4

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.8

6.4

103

592

I83.0

ICD-10 Finland

Varicose veins of lower extremities with ulcer

3.9

6.4

RT274

NOMESCO Finland

14.4

6.4

B01AC04

ATC

clopidogrel; oral

1.8

6.4

108

630

SBB10

NOMESCO Finland

Teeth copy

2.2

6.4

304

A01AB09

ATC

miconazole; local oral

1.9

6.4

515

S01KA02

ATC

hypromellose; ophthalmic

3.4

6.4

A40.3

ICD-10 Finland

Sepsis due to Streptococcus pneumoniae

8.2

6.3

R05

ICPC

Cough

1.5

6.3

221

1569

137

Kela drug reimbursment

Uraemia requiring dialysis

6.0

6.3

QDG20

NOMESCO Finland

Operation for chronic ulcer or fistula of skin of lower limb

6.0

6.3

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.8

6.3

554

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.5

6.3

234

1684

G62.8

ICD-10 Finland

Other specified polyneuropathies

9.3

6.3

V03AE02

ATC

sevelamer; oral

9.3

6.3

N02AC04

ATC

dextropropoxyphene; oral

2.8

6.3

134

J32.1

ICD-10 Finland

Chronic frontal sinusitis

18.1

6.3

4209X

ICD-9 Finland

Acute pericarditis, Other and unspecified acute pericarditis[PERICARDITIS ALIA DEFINITA SEU NUD]

+∞

6.3

E32.9

ICD-10 Finland

Disease of thymus, unspecified

+∞

6.3

6954B

ICD-9 Finland

Erythematous conditions, Lupus erythematosus[LUPUS ERYTHEMATOSUS DISCOIDES DISSEMINATUS]

+∞

6.3

I68.2*M32.1

ICD-10 Finland

Cerebral arteritis in systemic lupus erythematosus

+∞

6.3

C02KX01

ATC

bosentan; oral

26.8

6.2

M35.2

ICD-10 Finland

Behçet disease

26.8

6.2

TCC40

NOMESCO Finland

Closure of lacrimal canaliculus with plug

26.8

6.2

SBA00

NOMESCO Finland

Microbiological examinations

3.3

6.2

S01BA04

ATC

prednisolone; ophthalmic (corticosteroids, plain)

3.3

6.2

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.8

6.2

108

635

R59.1

ICD-10 Finland

Generalized enlarged lymph nodes

4.0

6.2

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

2.0

6.2

409

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

3.2

6.2

R53

ICD-10 Finland

Malaise and fatigue

1.6

6.2

188

1290

TNG11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in knee

5.4

6.2

B05DB

ATC

Hypertonic solutions

7.7

6.1

M01AX17

ATC

nimesulide; oral

1.5

6.1

224

1604

182

Kela drug reimbursment

Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide

3.8

6.1

N03AX14

ATC

levetiracetam; systemic

3.3

6.1

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

2.3

6.1

229

M34.0

ICD-10 Finland

Progressive systemic sclerosis

12.6

6.1

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

3.4

6.1

J94.8

ICD-10 Finland

Other specified pleural conditions

4.9

6.1

R04.0

ICD-10 Finland

Epistaxis

2.2

6.1

286

H16.0

ICD-10 Finland

Corneal ulcer

2.5

6.0

181

RJ410

NOMESCO Finland

10.1

6.0

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

2.2

6.0

287

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

2.0

6.0

350

R00.2

ICD-10 Finland

Palpitations

1.9

6.0

436

D06AX01

ATC

fusidic acid; topical (antibiotics for topical use)

1.8

6.0

549

I35.1

ICD-10 Finland

Aortic (valve) insufficiency

2.6

6.0

156

WW500

NOMESCO Finland

Blood transfusion

2.6

6.0

156

QXB99

NOMESCO Finland

Other procedure to treat skin wound, unspecified location

4.2

6.0

M01AH01

ATC

celecoxib; oral (coxibs)

1.6

6.0

178

1215

K75.9

ICD-10 Finland

Inflammatory liver disease, unspecified

5.6

6.0

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3015171) Extractable nuclear Ab [Units/volume] in Serum

364

394

13.28

322.46

2.0

1.2

u/ml

3.9

1.5

0.92

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

294

229

17.12

319.24

1.9

1.2

u/ml

59.3

43.2

0.53

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

713

280

69.85

307.65

6.9

1.3

g/l

0.2

22.57

684

267

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

383

279

20.47

307.65

2.0

1.2

u/ml

14.0

13.4

0.04

156

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

325

210

21.50

307.65

1.9

1.2

u/ml

1.6

6.2

0.49

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

387

299

19.37

307.65

2.0

1.2

u/ml

32.6

40.9

0.15

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

714

294

66.70

307.65

6.8

1.3

g/l

1.0

1.2

20.17

691

279

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

385

274

21.02

307.65

2.0

1.2

u/ml

20.0

2.3

2.89

134

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

525

320

30.33

307.65

8.2

1.6

—

(3037522) Nuclear Ab [Titer] in Serum

652

1368

10.17

307.65

2.6

1.3

titre

1056.7

513.2

9.96

406

290

(3039162) Centromere protein B Ab [Units/volume] in Serum

212

126

20.58

262.93

1.9

1.3

u/ml

50.4

54.0

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

189

161

13.95

191.32

1.6

1.2

u/ml

5.6

4.6

0.20

114

(42870588) Differential panel, method unspecified - Blood

785

3070

6.36

189.53

14.1

5.6

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

187

161

13.77

187.97

1.6

1.2

u/ml

7.5

1.8

1.97

108

(40759836) Histone Ab [Presence] in Serum by Immunoblot

143

20.38

180.87

1.6

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

143

20.38

180.87

1.6

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

143

20.38

180.87

1.6

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

143

20.13

179.82

1.6

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

143

20.13

179.82

1.6

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

143

20.13

179.82

1.6

1.1

—

(3005719) IgG [Mass/volume] in Serum or Plasma

344

675

6.95

178.66

3.9

2.9

g/l

11.3

10.3

3.27

328

617

(3001604) Monocytes [#/volume] in Blood

956

4641

8.82

175.02

15.9

5.5

e9/l

0.5

0.6

0.25

908

4034

(3006315) Basophils [#/volume] in Blood

958

4664

8.88

174.70

16.0

5.6

e9/l

0.0

3.53

909

4055

(3022096) Basophils/100 leukocytes in Blood

903

4199

7.27

172.23

16.5

5.7

0.7

0.80

880

3908

(3013115) Eosinophils [#/volume] in Blood

965

4835

8.81

167.04

16.4

5.8

e9/l

0.1

0.2

13.09

919

4268

(4268621)

148

105

16.12

165.93

2.8

2.2

—

(3006504) Eosinophils/100 leukocytes in Blood

909

4341

7.14

165.25

16.5

5.6

2.5

2.7

3.68

883

4040

(3019069) Monocytes/100 leukocytes in Blood

910

4362

7.13

164.33

17.2

5.9

9.3

8.3

15.61

882

4084

(3019198) Lymphocytes [#/volume] in Blood

955

4783

8.30

163.92

16.0

5.5

e9/l

1.6

1.9

10.05

914

4240

(3018010) Neutrophils/100 leukocytes in Blood

914

4442

7.09

161.02

16.0

5.5

58.5

56.8

3.98

886

4154

(3002030) Lymphocytes/100 leukocytes in Blood

916

4490

7.05

158.81

16.8

5.7

26.8

28.7

6.01

884

4188

(3013650) Neutrophils [#/volume] in Blood by Automated count

991

5433

8.93

144.71

18.9

8.6

e9/l

3.7

4.0

3.84

940

4776

(3004616) Nuclear Ab [Presence] in Serum

143

121

13.42

144.36

2.0

1.2

—

(3028026) IgM [Mass/volume] in Serum or Plasma

254

536

5.85

118.87

2.0

1.7

g/l

1.3

1.4

0.26

233

495

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

108

14.49

115.83

1.8

1.1

u/ml

46.0

79.2

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

204

360

6.72

114.66

1.5

1.6

u/ml

19.6

10.1

—

(3013293) Extractable nuclear Ab [Presence] in Serum

44.48

105.53

2.1

1.9

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

764

4090

3.81

94.93

3.4

2.3

nmol/l

82.2

77.5

4.73

730

3699

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

15.26

94.69

1.4

1.1

ratio

1.1

0.81

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

291

879

4.14

85.64

3.7

4.3

u/l

249.5

245.3

0.15

279

838

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

158

288

6.23

85.04

1.6

titre

658.2

163.1

0.91

(3002179) Metamyelocytes/100 leukocytes in Blood

250

685

4.42

83.76

6.0

3.9

0.3

0.6

2.14

150

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

166

324

5.85

83.13

2.5

2.0

g/l

1.5

0.02

148

284

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

561

2630

3.30

83.00

3.0

2.1

u/l

175.8

181.8

0.04

539

2479

(3037467) Urinalysis macro (dipstick) panel - Urine

974

6440

5.29

82.77

11.2

4.3

—

(3017181) Myelocytes/100 leukocytes in Blood

262

756

4.23

81.79

6.7

4.0

0.6

1.0

1.92

212

(3021440) Promyelocytes/100 leukocytes in Blood

249

714

4.21

78.13

6.9

4.0

0.0

0.1

4.16

190

(3013707) Erythrocyte sedimentation rate by Westergren method

1012

7006

6.23

78.13

13.5

4.0

mm/h

15.3

11.6

14.26

986

6496

(3018095) Leukocytes [#/volume] in Urine

613

3145

3.13

75.59

7.5

3.5

e6/l

86.9

87.2

0.00

467

2137

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

762

4426

3.32

75.56

9.9

6.2

mmol/l

1.2

0.80

666

3727

(3025159) Blasts/100 leukocytes in Blood

238

677

4.21

75.31

6.9

4.1

0.5

0.7

0.08

158

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

14.03

74.76

1.5

1.1

u/ml

55.8

10.3

—

(3002582) Erythrocytes [#/volume] in Urine

536

2591

3.07

72.74

6.0

3.0

e6/l

127.3

80.8

0.19

453

1962

(3000850) Epithelial cells [#/volume] in Urine

423

1792

3.20

72.28

4.6

2.5

e6/l

4.1

7.5

5.01

380

1579

(3020630) Protein [Mass/volume] in Serum or Plasma

229

654

4.15

71.85

1.8

2.7

g/l

66.1

67.3

1.38

213

601

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

1007

7106

5.66

71.68

16.3

7.0

u/l

73.8

76.3

0.77

993

6668

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

12.58

70.96

1.3

1.2

—

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

593

3088

2.98

69.40

7.2

3.1

—

(3004588) Protein electrophoresis panel - Serum or Plasma

207

563

4.29

69.22

1.7

2.3

—

(3035350) Ketones [Presence] in Urine by Test strip

761

4607

3.09

66.38

6.8

3.6

estimate

0.0

0.00

176

862

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

139

283

5.47

66.01

1.7

1.6

iu/ml

0.1

0.07

(3030467) Casts [#/volume] in Urine by Automated count

492

2367

2.94

65.77

6.0

2.9

e6/l

0.2

0.4

3.41

405

1761

(3009261) Glucose [Presence] in Urine by Test strip

768

4693

3.08

65.47

6.8

3.6

estimate

0.0

0.80

179

848

(3021601) Nitrite [Presence] in Urine by Test strip

761

4647

3.04

64.56

9.2

4.9

estimate

0.0

0.50

181

868

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

692

4031

2.91

63.81

7.9

5.4

mmol/l

1.2

0.72

653

3643

(3027945) Reticulocytes/100 erythrocytes in Blood

258

865

3.59

63.58

4.0

2.6

1.8

0.24

236

769

(3023368) Bacteria identified in Blood by Culture

449

2087

2.94

63.51

5.9

4.0

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

296

1123

3.23

59.42

3.4

2.3

21.0

22.3

0.92

267

959

(3004789) Transferrin [Mass/volume] in Serum or Plasma

312

1222

3.16

59.33

3.3

2.2

g/l

2.2

2.4

5.92

300

1125

(36304419) Bacteria [Presence] in Urine

475

2345

2.80

59.02

5.8

2.8

—

(3023520) Reticulocytes [#/volume] in Blood

206

625

3.82

58.62

3.3

2.6

e9/l

70.9

74.3

0.50

139

480

(3011412) CD3 cells [#/volume] in Blood

9.88

58.58

2.5

2.7

e9/l

0.9

1.2

1.49

(3007164) IgA [Mass/volume] in Serum or Plasma

425

1991

2.84

58.26

1.9

1.4

g/l

2.4

2.3

1.02

295

1184

(3022948) Iron [Moles/volume] in Serum or Plasma

330

1349

3.06

58.10

3.3

2.3

umol/l

11.6

13.3

4.13

319

1233

(3024561) Albumin [Mass/volume] in Serum or Plasma

654

3824

2.74

57.68

7.2

4.4

g/l

34.5

36.1

10.46

611

3548

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

105

189

6.03

56.70

1.4

1.6

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

456

2245

2.75

56.42

3.4

2.8

ng/l

1267.5

963.5

0.82

412

1860

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

147

6.74

55.89

6.0

6.4

iu/ml

338.1

163.9

0.94

(3034426) Prothrombin time (PT)

15.79

53.95

1.3

1.1

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

133

311

4.72

53.43

1.8

1.9

g/l

3.6

3.7

0.44

104

230

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

133

312

4.71

53.21

1.8

1.9

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

133

312

4.71

53.21

1.8

1.9

g/l

7.2

7.5

0.95

107

243

(40768443) Skin Pathology biopsy report

148

378

4.37

53.17

1.3

1.2

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

128

292

4.83

52.98

1.8

2.0

g/l

3.3

3.1

0.99

105

234

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

13.89

51.33

1.2

1.1

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

124

290

4.69

49.71

1.8

2.0

g/l

11.6

10.2

2.06

110

253

(3026782) Osmolality of Urine

359

1682

2.68

47.54

5.3

2.6

mosm/kgh2o

503.5

531.3

1.95

325

1435

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

116

267

4.74

47.37

1.9

2.2

g/l

0.3

0.7

0.96

107

238

(21494815) CD4 cells/100 lymphocytes in Specimen

9.48

47.23

2.1

51.4

46.9

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

422

2148

2.56

47.01

5.6

3.6

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

108

236

4.96

46.93

1.9

g/l

0.0

0.50

102

221

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

437

2263

2.54

46.91

2.8

2.1

mg/l

3.0

2.9

0.18

395

1924

(3021589) Normoblasts [#/volume] in Blood

661

4140

2.48

46.64

19.1

8.7

e9/l

0.0

0.45

594

3389

(40760892) CBC W Ordered Manual Differential panel - Blood

423

2165

2.54

46.46

10.1

4.3

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

14.64

45.25

1.2

1.0

—

(3018418) pH of Serum or Plasma

483

2663

2.44

44.75

5.8

3.5

7.4

0.93

500

(40758558) Short blood count panel - Blood

449

2409

2.45

44.03

12.2

6.2

—

(3020779) Urea [Moles/volume] in Serum or Plasma

186

641

3.29

42.73

10.5

7.2

mmol/l

9.6

8.5

1.29

179

614

(40768446) Kidney Pathology biopsy report

15.92

42.72

1.2

1.4

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

9.83

42.69

2.1

2.4

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

312

1432

2.64

42.38

4.6

2.5

e6/l

1.1

0.08

214

774

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

220

4.84

42.09

1.9

g/l

0.0

0.00

208

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

105

246

4.61

41.85

1.8

1.9

g/l

36.0

38.2

2.43

217

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

222

4.80

41.63

1.9

g/l

0.0

0.00

209

(3042936) Bacteria identified in Isolate by Culture

274

1209

2.68

40.03

2.7

1.9

—

(3007566) Smooth muscle Ab [Titer] in Serum

217

4.75

39.96

1.3

1.2

titre

265.7

98.0

—

(3034770) Mitochondria Ab [Titer] in Serum

230

4.63

39.84

1.3

1.2

titre

1395.0

1108.5

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

250

1059

2.76

39.53

1.6

1.5

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

252

1076

2.74

39.20

9.0

5.0

mmol/l

1.1

1.0

3.22

238

988

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

12.66

38.56

1.4

1.1

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

9.05

37.75

2.0

2.3

12.6

13.3

0.10

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

281

1293

2.57

37.41

2.3

1.8

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

354

1832

2.37

36.30

1.3

iu/ml

50.0

31.8

1.29

120

585

(3004809) Band form neutrophils/100 leukocytes in Blood

136

5.51

35.69

2.6

3.0

1.0

1.1

0.13

110

(3031040) Bacteria [#/volume] in Urine by Automated count

833

6193

2.40

34.43

6.5

4.4

e6/l

1229.8

2078.3

0.28

(3032080) INR in Blood by Coagulation assay

528

3282

2.16

34.14

12.9

7.7

inr

1.3

1.2

2.61

154

982

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

686

4735

2.18

33.65

7.1

5.7

umol/l

10.1

10.4

0.29

654

4470

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

171

4.83

33.61

1.3

1.4

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

337

1760

2.32

33.40

1.3

u/ml

13.4

12.2

0.11

141

680

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

7.44

32.84

1.3

1.1

titre

242.4

73.3

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

277

1337

2.43

32.79

5.2

2.6

e6/l

2.4

3.9

1.89

180

683

(44806071)

18.99

32.69

1.2

1.1

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

7.70

32.43

2.5

e6/l

547.7

695.6

0.67

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

215

4.31

32.28

2.8

2.5

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

225

4.21

32.05

1.7

3.6

mg/l

39.7

39.3

0.01

175

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

7.58

31.99

1.9

1.4

u/l

5.7

6.9

0.46

(3044009) aPTT.lupus sensitive (LA screen)

19.65

31.90

1.6

1.3

—

(3019174) dRVVT (LA screen)

19.65

31.90

1.5

1.2

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

14.15

31.45

1.5

1.1

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

212

921

2.61

31.28

1.9

2.1

nmol/l

349.8

374.0

0.97

195

848

(3034860) Kappa light chains.free [Mass/volume] in Serum

225

4.16

31.21

1.7

3.6

mg/l

48.6

70.4

0.34

177

(3017732) Neutrophils [#/volume] in Blood

166

639

2.88

30.96

3.2

2.8

e9/l

3.7

4.0

0.92

110

513

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

258

3.89

30.24

2.2

2.1

ug/l

98.8

234.5

3.76

235

(3037121) Protein [Mass/volume] in Urine

103

303

3.65

29.97

4.6

3.1

g/l

0.4

0.3

0.51

106

(3009508) Creatinine [Moles/volume] in Urine

439

2641

2.10

29.86

5.7

3.0

mmol/l

6.8

7.1

0.67

388

2249

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

155

4.75

29.78

1.3

1.4

u/ml

136.6

109.5

0.37

(3000475) Leukocytes [#/volume] in Synovial fluid

193

4.33

29.73

1.6

e6/l

12329.1

14562.1

0.13

145

(3037756) Immunofixation for Serum or Plasma

172

4.54

29.67

1.3

1.7

—

(3019225) pH of Specimen

205

898

2.57

29.62

6.2

3.7

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

219

4.07

29.00

1.6

3.5

ratio

1.3

2.1

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

6.28

28.64

2.8

59.1

53.1

0.86

(3007853) Bacteria identified in Skin by Aerobe culture

220

1011

2.47

28.64

2.2

1.6

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

150

571

2.88

28.46

3.8

2.9

ng/l

216.6

166.0

0.61

140

523

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

162

4.55

28.21

1.2

1.3

u/ml

366.2

265.6

0.67

100

(3001122) Ferritin [Mass/volume] in Serum or Plasma

633

4420

2.01

27.81

4.0

2.8

ug/l

146.1

90.5

6.23

602

4108

(3018677) aPTT in Platelet poor plasma by Coagulation assay

255

1272

2.31

27.48

3.0

1.9

30.7

29.3

2.02

247

1230

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

174

4.36

27.46

1.2

1.3

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

166

686

2.67

26.84

1.3

1.4

—

(3012516) Albumin [Mass/volume] in Urine

404

2436

2.04

26.62

5.7

3.1

mg/l

856.7

352.1

0.83

278

1467

(3020682) Albumin/Creatinine [Ratio] in Urine

418

2557

2.02

26.41

6.9

3.9

mg/mmol

21.5

8.0

2.30

298

1540

(3024980) IgG subclass 4 [Mass/volume] in Serum

150

4.54

26.28

1.4

1.7

g/l

0.5

0.8

1.03

114

(3000494) Fungus identified in Specimen by Culture

228

1106

2.34

26.09

1.7

1.4

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

11.02

26.07

3.1

3.0

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

146

4.52

25.33

1.6

1.4

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

167

712

2.58

25.28

5.0

3.5

ng/l

83.4

77.5

0.53

153

634

(3045424) Erythrocytes [Presence] in Urine

144

4.50

24.86

2.1

1.4

—

(21494814) CD8 cells/100 lymphocytes in Specimen

10.23

24.79

2.0

2.1

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

263

1386

2.18

24.48

4.2

3.3

mmol/l

0.8

0.02

247

1290

(3026008) Bacteria identified in Urine by Culture

454

2917

1.94

24.43

3.5

2.9

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

190

3.98

24.42

5.5

3.6

59.2

58.6

0.13

190

(3008757) Leukocyte morphology finding [Identifier] in Blood

5.53

24.17

3.4

3.6

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

115

419

2.95

23.50

1.6

2.0

u/l

40.7

39.9

0.15

101

376

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

286

1580

2.09

23.44

1.6

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

207

3.76

23.12

4.4

2.8

u/ml

0.3

0.4

0.52

115

(3021447) Carbon dioxide [Partial pressure] in Venous blood

162

710

2.50

23.05

4.8

3.3

kpa

5.8

0.05

156

689

(3030905) Polymorphonuclear cells [#/volume] in Blood

185

3.91

22.89

5.4

3.3

e9/l

3.5

4.2

2.02

185

(3022217) INR in Platelet poor plasma by Coagulation assay

199

960

2.31

22.84

31.1

21.1

inr

1.4

1.2

0.53

132

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

14.25

22.83

1.2

1.3

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

289

3.30

22.78

2.5

1.7

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

221

3.62

22.43

1.5

1.3

—

(3026493) Urate [Moles/volume] in Serum or Plasma

367

2246

1.95

22.39

3.8

2.4

umol/l

3362.0

5177.4

0.43

327

1956

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

319

3.16

22.34

2.5

1.9

—

(3012544) pH of Venous blood

163

728

2.45

22.23

4.8

3.4

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

8.09

22.22

1.2

1.7

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

8.09

22.22

1.2

1.7

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

6.21

22.13

1.2

1.3

titre

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

523

3600

1.86

22.12

2.2

1.9

pmol/l

99.0

96.6

0.56

287

1808

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

204

3.71

22.07

1.6

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

476

3183

1.87

22.05

3.6

3.3

mmol/l

2.3

2.4

5.96

422

2802

(3048929) Epstein Barr virus Ab [Presence] in Serum

295

3.23

22.03

1.2

1.3

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

127

505

2.71

22.00

4.9

3.5

kpa

5.1

0.01

117

479

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

296

3.22

21.90

2.2

1.9

ug/l

1.8

2.0

0.08

265

(3002032) Base excess in Venous blood by calculation

158

702

2.46

21.78

4.8

3.3

mmol/l

1.7

2.0

0.42

128

562

(3022313) Gas panel - Capillary blood

102

364

2.99

21.59

5.0

3.6

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

355

2177

1.93

21.34

2.5

1.7

mg/l

1.4

1.0

2.64

286

1643

(3009343) pH of Capillary blood

124

499

2.67

20.96

4.8

3.5

7.4

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

10.66

20.94

1.8

2.4

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

6.46

20.64

2.3

2.7

42.4

47.4

0.41

(3033658) Prothrombin time (PT) actual/Normal

363

2268

1.89

20.46

5.8

3.5

93.1

94.9

0.64

354

2202

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

280

1605

2.00

20.36

4.8

3.5

ng/l

509.2

281.6

0.47

220

1133

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

474

3223

1.82

20.35

4.1

3.3

ng/l

295.8

44.3

0.73

334

2012

(3017817) Protein [Mass] in Urine collected for unspecified duration

5.85

20.33

2.9

2.3

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

183

895

2.25

20.17

2.2

1.7

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

1053

9384

3.55

20.12

32.1

12.6

mg/l

18.1

20.9

2.93

962

7306

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

156

3.94

19.95

1.5

1.3

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

11.25

19.81

1.2

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

11.25

19.81

1.2

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

11.25

19.81

1.2

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

11.25

19.81

1.2

1.1

—

(3000093) Morphology [Interpretation] in Blood Narrative

5.68

19.71

1.1

1.2

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

313

1887

1.92

19.52

1.8

—

(3048689) Calprotectin [Mass/mass] in Stool

227

1227

2.07

19.32

2.4

2.2

ug/g

96.9

110.5

0.39

193

957

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

302

3.04

19.31

3.7

2.1

97.1

92.9

0.95

281

(3021788) Differential panel - Synovial fluid

151

3.93

19.22

1.6

1.7

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

135

590

2.47

19.19

1.9

1.6

—

(3019309) Folate [Moles/volume] in Red Blood Cells

270

1558

1.97

19.12

1.9

1.7

nmol/l

1112.5

1218.2

1.22

219

1174

(3045414) Leukocytes [Presence] in Urine

107

421

2.71

18.86

2.4

1.8

—

(3029937) Albumin [Presence] in Urine by Test strip

378

2446

1.83

18.73

8.2

4.0

estimate

0.0

1.08

176

856

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

366

2347

1.84

18.67

1.4

1.3

u/ml

1.5

1.7

0.13

632

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

181

909

2.19

18.60

2.2

1.7

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

116

482

2.57

18.33

4.7

3.5

mmol/l

1.4

1.8

0.55

365

(3000991) Gas panel - Venous blood

138

622

2.39

18.31

8.1

7.5

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

4.71

18.09

1.6

1.7

—

(40760888) Immunoglobulin light chains.free panel - Serum

172

3.63

18.08

1.5

4.0

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

446

3057

1.77

18.05

4.2

3.0

u/l

32.1

29.3

1.49

428

2922

(3021960) Folate [Moles/volume] in Serum or Plasma

327

2044

1.85

17.99

1.6

1.5

nmol/l

20.4

21.6

0.81

294

1761

(3029075) Extractable nuclear Ab panel - Serum

7.73

17.88

1.7

1.0

—

(40768797) Stomach Pathology biopsy report

240

1362

1.97

17.69

1.3

1.2

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

269

3.04

17.50

1.6

2.1

mg/l

11.3

11.4

0.06

248

(3041096) Erythrocytes [Presence] in Urine by Automated

385

2567

1.77

16.89

6.8

3.3

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

373

2.69

16.80

5.4

3.2

mmol/l

24.1

24.2

0.15

337

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

259

3.03

16.79

1.3

1.2

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

197

3.33

16.63

1.6

1.7

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

234

3.13

16.57

4.1

3.8

mg/l

1.6

1.5

0.62

217

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

341

2207

1.79

16.49

2.8

2.1

—

(3036489) Thrombin time

359

2.70

16.46

3.6

2.0

21.5

21.1

0.26

317

(3044640) Blood type and Crossmatch panel - Blood

422

2917

1.72

16.11

3.0

2.2

—

(3044941) Cell count panel - Synovial fluid

128

3.87

16.05

1.5

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

662

5200

1.68

15.32

5.7

4.4

mmol/l

6.2

6.6

5.74

633

4816

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

4.39

15.09

1.2

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

412

2868

1.70

15.09

2.9

2.4

u/l

56.7

56.1

0.13

389

2627

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

102

439

2.46

14.92

2.0

1.6

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

154

789

2.11

14.88

2.3

2.2

g/l

0.2

3.02

140

749

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

140

692

2.17

14.83

2.7

2.4

au/ml

65.2

23.3

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

150

3.52

14.81

1.7

1.6

—

(36660697) Celiac disease serology panel - Serum

159

828

2.07

14.71

1.2

—

(3013512) EKG study

370

2519

1.70

14.62

4.4

3.5

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

147

3.52

14.53

1.6

1.7

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

488

3577

1.65

14.51

7.4

3.8

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

181

994

1.98

14.44

2.7

umol/l

6.7

0.02

159

845

(4306422)

153

3.45

14.38

1.4

1.2

—

(3024354) Oxygen [Partial pressure] in Venous blood

123

590

2.22

14.02

3.5

2.8

kpa

4.4

4.5

0.26

116

569

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

4.38

13.91

1.7

—

(3052851) Hemolysis interference index of Serum or Plasma

260

2.81

13.76

3.8

3.1

—

(3012441) Differential panel - Pleural fluid

5.30

13.48

1.6

1.4

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

160

3.29

13.41

1.1

1.2

—

(4062490)

3.94

13.15

1.4

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

5.30

13.00

1.2

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

5.68

12.93

1.7

1.9

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

5.68

12.93

1.7

1.9

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

5.68

12.93

1.7

1.9

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

5.68

12.93

1.7

1.9

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

154

3.28

12.86

1.5

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

154

3.28

12.86

1.5

1.3

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

6.47

12.85

1.4

1.3

ug/l

8.1

8.3

0.07

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

7.14

12.73

2.3

2.6

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

6.89

12.32

2.2

5.0

mg/l

61.3

68.6

0.23

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

230

2.80

12.23

1.6

—

(3023199) Leukocytes [#/volume] in Pleural fluid

4.68

12.17

1.6

1.2

e6/l

4641.5

1721.0

0.89

(3028308) Erythrocytes [#/volume] in Pleural fluid

4.91

11.94

1.5

1.2

e6/l

56056.4

46651.6

0.06

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

4.22

11.84

1.2

1.0

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

152

3.18

11.79

1.4

—

(3028433) Virus identified in Specimen by Culture

6.15

11.69

1.4

1.3

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

103

3.68

11.68

2.0

1.7

56.8

56.2

0.03

(3039744) RNA polymerase III Ab [Units/volume] in Serum

30.38

11.66

1.1

1.2

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

128

3.37

11.58

1.4

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

3.87

11.53

1.5

1.6

—

(3042733) HLA Ab [Presence] in Serum

8.43

11.51

5.8

2.5

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

150

3.16

11.39

1.2

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

3.73

11.29

1.4

g/l

7.4

6.5

0.61

(3028192) IgG subclass 2 [Mass/volume] in Serum

3.73

11.29

1.4

g/l

2.9

2.7

0.15

(3024139) IgG subclass 3 [Mass/volume] in Serum

3.73

11.29

1.4

g/l

0.5

0.3

1.17

(40761535) Cells panel - Urine sediment

131

699

1.99

11.24

7.7

3.4

—

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

5.61

11.20

2.5

2.1

ug/l

78.3

79.1

0.01

(40768806) Pleura Pathology biopsy report

4.44

11.02

1.4

1.7

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

220

2.73

10.99

1.5

1.2

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

3.70

10.85

1.2

u/l

40.8

53.6

1.04

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

120

633

2.00

10.62

2.2

2.3

ug/l

7.1

6.3

0.22

103

563

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

4.30

10.60

2.1

1.5

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

3.71

10.58

9.5

7.3

mg/l

12.6

12.1

0.24

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

10.10

10.45

2.0

3.8

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

5.20

10.34

1.1

1.2

—

(3000060) B lymphocytes [#/volume] in Blood

7.23

10.15

1.7

2.3

e6/l

186.7

183.3

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

975

8860

1.85

9.93

24.7

11.3

ml/min/173m2

84.0

83.8

0.11

880

7219

(3044927) Protein electrophoresis panel - Urine

3.68

9.86

1.2

1.1

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

4.96

9.81

1.6

2.4

umol/l

55.1

46.3

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

553

4429

1.50

9.77

5.1

3.9

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

128

3.12

9.58

1.3

1.1

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

10.09

9.55

2.0

1.6

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

161

2.87

9.53

1.3

1.1

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

5.74

9.29

1.6

1.3

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

115

3.20

9.25

1.4

—

(44790048)

100

3.37

9.22

1.6

1.4

—

(44806118)

100

3.37

9.22

1.6

1.4

—

(44790049)

100

3.37

9.22

1.6

1.4

—

(44790047)

100

3.37

9.22

1.6

1.4

—

(3026250) Tacrolimus [Mass/volume] in Blood

5.37

9.18

30.8

25.5

ug/l

6.2

7.1

0.93

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

199

2.64

9.18

1.4

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

4.33

9.15

1.1

—

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

6.00

9.14

1.4

2.3

174.6

127.3

1.40

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

5.55

8.99

1.6

2.2

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

5.55

8.99

1.6

2.2

—

(3019150) Specific gravity of Urine by Refractometry

285

2014

1.56

8.93

7.0

4.0

kg/l

1.0

0.94

285

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

4.72

8.84

1.4

1.2

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

151

2.85

8.83

1.3

1.1

115.6

118.0

0.14

138

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

5.38

8.70

1.6

2.2

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

279

2.33

8.69

1.3

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

4.44

8.64

1.4

1.2

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

6.43

8.54

1.1

—

(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay

6.43

8.54

1.1

81.6

105.3

1.23

(3005322) IgE [Units/volume] in Serum or Plasma

121

689

1.85

8.51

1.2

u/ml

146.5

188.7

0.36

111

632

(4027681)

3.79

8.37

1.3

1.1

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

102

3.20

8.28

1.1

1.3

—

(3045788) Cell count panel - Pleural fluid

4.26

8.22

1.5

1.3

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

205

2.51

8.16

3.2

2.9

mmol/l

23.8

25.0

1.09

186

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

242

1678

1.57

8.16

2.8

2.7

mmol/l

2.5

2.4

0.15

215

1472

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

125

732

1.80

8.03

4.8

3.5

mmol/l

1.2

1.14

117

623

(3000570) Elastase.pancreatic [Mass/mass] in Stool

276

2.28

8.02

1.3

1.4

ug/g

354.4

301.1

1.21

159

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

7.13

8.00

1.2

1.1

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

175

1134

1.65

7.79

4.4

4.2

35.3

32.6

2.48

133

775

(3044290) Cell count panel - Cerebral spinal fluid

198

2.49

7.75

1.2

1.5

—

(3023419) Bacteria identified in Sputum by Culture

101

3.13

7.75

2.4

2.9

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

3.39

7.69

1.6

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

3.39

7.69

1.6

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

3.39

7.69

1.6

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

113

2.98

7.59

2.2

2.6

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

8.40

7.59

1.0

6.0

—

(3016018) Differential panel - Cerebral spinal fluid

3.21

7.57

1.1

1.5

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

1021

9555

1.89

7.48

25.9

13.9

mmol/l

139.2

139.6

5.13

1006

9300

(3014111) Lactate [Moles/volume] in Serum or Plasma

117

687

1.79

7.45

7.2

6.1

mmol/l

1.3

0.34

112

656

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

120

2.89

7.42

1.6

1.5

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

1022

9579

1.88

7.28

26.4

14.0

mmol/l

3.9

0.71

1006

9304

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

498

1.90

7.25

1.7

1.5

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

6.93

7.16

1.2

1.1

ug/l

1.3

61.4

—

(3028626) Oxygen [Partial pressure] in Capillary blood

182

2.48

7.08

2.7

3.2

kpa

8.5

8.3

0.40

174

(40768804) Tissue Pathology biopsy report

491

4002

1.41

7.08

2.3

2.0

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

272

2.20

7.03

1.2

1.1

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

6.05

6.91

1.1

1.8

—

(3022145) Colonoscopy Study observation

158

1029

1.62

6.87

1.4

1.3

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

3.39

6.85

1.0

1.1

u/l

1.0

1.1

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

3.18

6.74

1.2

1.1

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1052

9991

2.08

6.67

24.9

9.8

u/l

24.6

24.3

0.29

1041

9659

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

5.77

6.59

1.1

—

(4035726)

129

806

1.68

6.59

1.4

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

117

2.79

6.58

1.5

1.4

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

3.05

6.53

2.4

3.5

—

(3042631) Mycobacterium sp identified in Specimen

112

2.82

6.52

2.8

2.5

—

(4015189)

6.16

6.44

2.6

3.6

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

119

2.74

6.38

1.6

1.4

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

119

2.74

6.38

1.6

1.4

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

4.10

6.37

1.0

1.1

iu/ml

288.2

151.3

0.54

(3024932) HLA-DR beta [Type]

5.50

6.29

1.0

1.1

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

3.88

6.27

1.2

1.1

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

3.10

6.22

1.5

1.3

e6/l

2454.4

192577.4

0.89

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

3.10

6.22

1.2

2.0

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

115

2.74

6.22

1.2

1.4

—

(3000034) Microalbumin [Mass/volume] in Urine

3.24

6.17

5.0

3.3

mg/l

98.8

13.8

0.87

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

116

2.72

6.12

1.6

1.4

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

116

2.72

6.12

1.6

1.4

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

117

2.70

6.03

1.6

1.4

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

3.49

6.03

1.2

1.1

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

5.26

6.01

1.1

—

(3024471) HLA-A [Type]

5.26

6.01

1.0

—

(3017704) Immunofixation for Urine

3.91

6.00

1.1

1.7

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

135

2.57

5.99

1.2

1.4

—

(3021901) Oxygen saturation in Capillary blood

141

2.53

5.99

2.3

2.6

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

257

2.12

5.95

1.3

1.2

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

3.56

5.90

1.3

1.1

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

4.21

5.83

1.1

1.0

92.2

96.1

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

5.55

5.81

1.0

1.1

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

114

2.68

5.77

1.1

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

3.74

5.66

1.2

1.0

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

3.74

5.66

1.2

1.0

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

130

848

1.60

5.60

2.8

2.3

u/l

39.2

38.4

0.07

112

700

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

128

2.54

5.57

1.1

—

(1761868) Lipid panel - Serum or Plasma

271

3466

0.71

5.51

2.7

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

3.99

5.45

1.1

1.0

90.7

90.5

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

3.76

5.38

1.5

1.3

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

3.76

5.38

1.5

1.3

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

101

2.72

5.36

1.1

1.0

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

119

2.56

5.32

1.1

1.2

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

4.37

5.30

1.8

1.3

—

(21494890) Protein electrophoresis panel - 24 hour Urine

3.01

5.28

1.1

2.2

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

4.66

5.26

1.1

1.2

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

216

2.13

5.21

1.2

1.4

e6/l

11.5

11.4

0.00

162

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

850

7782

1.40

5.17

4.7

4.4

pmol/l

14.7

14.6

0.20

792

7159

(3027456) Digoxin [Moles/volume] in Serum or Plasma

137

2.38

4.86

3.4

3.2

nmol/l

0.8

0.00

109

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

3.19

4.77

1.7

1.5

u/l

19.0

4.9

0.52

(40768441) Liver Pathology biopsy report

2.98

4.73

1.3

1.4

—

(3036782) Glucose [Moles/volume] in Pleural fluid

3.05

4.68

1.5

1.2

mmol/l

7.4

7.0

0.20

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

704

6301

1.32

4.68

3.8

3.0

u/l

58.8

42.3

2.00

668

5896

(40768795) Lymph node Pathology biopsy report

2.67

4.67

1.3

1.1

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

3.52

4.62

1.0

1.2

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

2.96

4.45

2.0

1.7

26.5

40.1

0.68

(3009871) Measles virus Ab [Titer] in Serum

4.03

4.44

1.7

—

(3051593) INR in Capillary blood by Coagulation assay

4.03

4.44

3.6

9.7

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

119

2.39

4.35

3.1

2.2

mg/l

35.1

28.9

0.17

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

3.53

4.34

1.1

2.3

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

3.07

4.25

1.2

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

271

1.89

4.19

1.3

1.2

—

(3001019) Free T4 and TSH panel - Serum or Plasma

652

0.49

4.08

1.5

1.8

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

3.54

4.05

1.4

1.3

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

3.54

4.05

1.4

1.3

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

244

1917

1.35

3.98

1.6

1.7

pmol/l

91866471.3

24969150.2

0.49

209

1598

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

458

1.66

3.97

2.4

2.3

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

3.15

3.94

2.1

1.6

—

(3003327) Ova and parasites identified in Stool by Light microscopy

344

1.76

3.93

2.4

1.7

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

2.66

3.91

1.8

1.7

—

(21494434) Karyotype in Bone marrow

2.66

3.91

1.1

1.2

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

165

2.09

3.89

1.3

1.2

—

(3036048) Francisella tularensis Ab [Titer] in Serum

6.04

3.82

1.0

1.1

—

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

126

892

1.47

3.76

7.4

7.9

kpa

4.8

5.1

2.65

117

858

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

949

8982

1.40

3.70

5.8

5.1

mu/l

1.9

2.0

0.30

900

8320

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

6.71

3.67

1.1

1.3

—

(3016502) Oxygen saturation in Arterial blood

112

782

1.48

3.59

7.5

8.5

95.1

95.9

0.43

107

759

(3027801) Oxygen [Partial pressure] in Arterial blood

125

892

1.45

3.58

7.4

7.9

kpa

11.6

12.5

1.55

117

858

(3024928) Oxygen saturation in Venous blood

164

2.04

3.57

3.2

2.9

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

394

1.66

3.54

10.0

11.5

—

(3024263) Appearance of Synovial fluid

3.20

3.50

2.2

1.8

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

10.05

3.50

2.8

4.7

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

10.05

3.50

21.2

12.5

mmol/l

4.9

6.8

—

(3045142) Bone marrow Pathology biopsy report

2.39

3.50

1.2

1.3

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

3.57

3.48

1.1

1.4

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

3.57

3.48

1.5

2.2

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

119

846

1.46

3.48

3.3

4.0

ug/l

11.3

15.1

0.22

678

(3025941) Bacteria identified in Stool by Culture

547

1.56

3.48

1.3

1.2

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

166

2.02

3.47

1.2

1.1

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

706

6440

1.27

3.46

3.6

3.3

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

283

1.77

3.41

1.2

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

2.68

3.40

1.1

1.2

—

(21494755) Public health laboratory ask at order entry panel

980

0.62

3.38

1.2

1.3

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

5.75

3.34

1.1

1.0

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

2.36

3.26

1.1

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

4.77

3.24

1.3

1.1

—

(3003396) Base excess in Arterial blood by calculation

123

893

1.42

3.23

7.3

7.9

mmol/l

0.6

1.3

0.78

710

(3000492) Spirometry study

126

920

1.42

3.20

1.9

1.4

—

(3008536) Aspergillus sp Ab [Presence] in Serum

5.36

3.19

1.1

2.4

—

(3044889) 12 lead EKG panel

699

6399

1.25

3.18

4.3

3.5

—

(3011648) Oxygen content in Venous blood

2.65

3.14

3.1

1.8

11.1

10.8

0.08

(4010399)

687

1.47

3.10

1.7

1.4

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

5.86

3.02

2.0

1.6

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

5.86

3.02

2.4

1.8

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

692

1.46

2.99

2.7

3.3

pmol/l

4.1

4.5

4.12

606

(3019768) Coxiella burnetii Ab [Presence] in Serum

10.04

2.98

1.0

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

10.04

2.98

1.0

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

2.42

2.98

2.2

2.1

—

(3014271) Vancomycin [Susceptibility]

3.16

2.93

3.3

2.4

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

2.85

2.92

1.2

1.5

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

185

1.86

2.90

1.6

2.3

g/l

130.6

130.5

0.01

135

(3004446) Plasmodium sp identified in Blood by Light microscopy

6.69

2.87

2.2

2.4

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

283

1.69

2.87

1.3

1.2

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

2.79

2.82

1.2

1.5

—

(40757373) Influenza virus identified in Isolate

4.47

2.80

2.1

1.6

—

(3035320) C reactive protein [Mass/volume] in Body fluid

2.56

2.79

2.9

2.1

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

568

1.48

2.78

1.0

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

3.94

2.77

1.0

1.2

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

8.36

2.75

1.4

1.2

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

111

2.09

2.74

2.6

1.8

u/ml

21.4

40.2

0.21

104

(40761536) Microorganisms panel - Urine sediment

110

808

1.40

2.73

9.5

3.8

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

885

0.65

2.72

1.4

1.7

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

2.45

2.71

1.2

1.6

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

2.61

2.71

1.0

1.4

—

18.1

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

6.03

2.70

1.2

1.5

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

112

2.08

2.68

1.1

1.3

pmol/l

290.8

310.3

0.14

(42529406) Shigella sp [Presence] in Stool by Culture

289

1.65

2.67

1.3

1.2

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

140

1.95

2.67

1.0

—

(3035880) pH of Pleural fluid

3.14

2.65

1.1

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

2.41

2.64

1.1

nmol/l

0.4

1.0

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

171

1.84

2.56

6.4

2.7

—

(3023410) Appearance of Cerebral spinal fluid

101

2.10

2.54

1.2

1.5

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

2.62

2.53

1.2

1.3

—

(3002385) Erythrocyte distribution width [Ratio]

845

7986

1.25

2.49

35.0

15.3

14.0

13.6

6.73

840

7823

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

4.40

2.47

2.1

1.0

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

3.83

2.46

1.0

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

2.47

2.45

1.2

1.4

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

197

1.75

2.41

1.3

1.4

u/l

27.6

27.2

0.02

167

(3008037) Lactate [Moles/volume] in Venous blood

175

1.79

2.40

3.2

2.7

mmol/l

1.1

1.5

5.86

169

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

6.27

2.37

1.2

1.3

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

291

1.61

2.37

3.8

2.9

u/ml

990.6

679.1

0.13

248

(3022621) pH of Urine by Test strip

623

1.41

2.34

4.4

2.6

—

(3017569) Oxygen content in Arterial blood

2.87

2.31

4.9

4.1

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

891

8498

1.25

2.26

5.8

5.3

mmol/mol

38.0

39.1

3.66

846

7930

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

3.91

2.25

1.0

1.2

—

(3013247) Albumin in CSF/Albumin in Serum or Plasma

3.91

2.25

1.0

mg/g

5.9

6.1

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.12

2.23

1.1

1.2

—

(3003181) Sodium [Moles/volume] in Urine

150

1.82

2.21

1.3

1.4

mmol/l

50.9

63.2

0.84

128

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

721

1.36

2.13

4.2

2.4

ml/min/173m2

63.3

69.4

0.85

293

(3016650) Hepatitis A virus Ab [Presence] in Serum

138

1.83

2.10

1.0

1.1

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

2.57

2.10

1.1

1.0

—

(40765096) Chromosome analysis panel by Banding

3.22

2.09

1.0

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

235

1988

1.23

2.09

1.6

1.5

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

5.02

2.07

1.2

1.3

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

2.52

2.01

1.0

1.1

124.1

111.5

0.78

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

119

1.87

1.98

1.0

1.1

—

(40767503) Oxygen content in Capillary blood by calculation

157

1.74

1.94

2.3

2.6

16.6

16.4

0.10

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

2.98

1.94

1.1

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

3.76

1.93

1.3

1.1

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

348

1.49

1.93

1.3

miu/ml

213.6

246.8

0.23

164

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

2.87

1.86

1.1

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

2.87

1.86

1.1

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

2.87

1.86

1.1

1.2

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

3.54

1.84

1.2

—

(3026389) Candida sp identified in Specimen by Organism specific culture

130

1.79

1.82

1.6

1.3

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

4.18

1.82

1.2

1.3

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

4.18

1.82

1.2

1.1

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

2.77

1.79

3.5

5.3

—

(3038515) Glucose [Moles/volume] in Venous blood

162

1.68

1.76

3.4

2.9

mmol/l

6.3

7.6

2.61

157

(3051611) Lipemic interference index of Serum or Plasma

1.99

1.75

4.4

2.9

—

(3003129) Base excess in Capillary blood by calculation

3.35

1.75

1.7

1.3

mmol/l

0.3

1.9

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

281

0.53

1.71

1.4

1.5

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

402

1.41

1.67

1.5

1.6

—

(1616796) Gas panel - Central venous blood

165

1.65

1.66

4.3

3.5

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

626

0.69

1.63

1.3

1.4

—

(3050129) First trimester maternal screen panel - Serum or Plasma

399

0.62

1.60

1.4

1.5

—

(3044242) Glucose [Moles/volume] in Arterial blood

2.34

1.60

4.9

3.7

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

2.08

1.60

1.0

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

600

0.69

1.60

1.5

—

(3047189) Immunofixation for 24 hour Urine

2.51

1.60

1.1

1.7

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

336

0.59

1.58

1.5

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

336

0.59

1.58

1.5

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

334

0.59

1.55

1.5

1.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

334

0.59

1.55

1.5

1.4

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

2.28

1.53

1.1

miu/ml

1194.2

1775.9

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

283

0.56

1.53

1.6

1.5

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

1.96

1.49

1.6

1.3

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

125

1.69

1.44

1.5

1.3

nmol/l

—

(3037556) Urate [Mass/volume] in Serum or Plasma

2.74

1.43

1.3

1.0

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

129

1069

1.23

1.42

1.5

1.7

1.4

0.50

110

952

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

362

0.63

1.42

1.6

1.5

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

109

887

1.25

1.41

4.1

3.1

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

2.26

1.40

1.1

1.2

—

(4211845)

2.18

1.40

6.2

2.8

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

274

0.58

1.38

1.6

1.4

—

(3006462) Nitrate [Presence] in Urine

2.20

1.37

6.8

3.0

—

(4024509)

1.84

1.36

1.5

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

183

1.54

1.35

1.8

1.1

—

(3005033) Fetal Nuchal fold Thickness US

272

0.58

1.35

1.6

1.4

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

1.82

1.31

1.3

1.1

—

(3032773) Endomysium IgG Ab [Titer] in Serum

106

1.71

1.30

1.1

—

(3010421) pH of Blood

210

1.49

1.29

4.5

3.3

7.4

0.40

167

(3049717) Cytology report of Urine Cyto stain

235

1.46

1.28

2.3

2.5

—

(3019060) Gas panel - Arterial blood

511

1.31

1.28

3.7

6.4

—

(3051651) Icteric interference index of Serum or Plasma

2.09

1.28

5.6

3.1

—

(3025130) Human papilloma virus identified in Specimen

179

1.52

1.24

2.1

1.8

—

(3033799) Differential panel - Peritoneal fluid

2.64

1.21

1.8

1.5

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

265

1.41

1.18

1.4

1.3

u/l

12.5

12.2

0.04

211

(3000330) Specific gravity of Urine by Test strip

439

1.31

1.16

5.9

3.3

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

808

1.23

1.16

1.3

1.2

iu/ml

84.0

145.7

1.19

322

(3032057) Clostridioides difficile [Presence] in Stool

2.51

1.15

1.4

2.1

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

191

1.48

1.14

2.4

ug/min

95.6

115.3

0.14

112

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

280

2530

1.14

1.7

1.6

mmol/l

1.3

0.26

248

2142

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

1.91

1.12

1.7

u/field

1.5

2.7

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

127

1.59

1.12

1.4

1.5

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

135

1.57

1.12

1.6

1.2

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

2.39

1.09

1.4

1.2

31.2

53.2

—

(4094501)

229

0.61

1.06

1.0

1.1

—

(3012501) Base excess in Blood by calculation

170

1.48

1.05

5.2

3.5

mmol/l

3.1

2.6

0.37

116

(40761539) Cells [Type] in Urine sediment by Light microscopy

2.28

1.03

1.6

1.1

—

(3001893) Eosinophils/100 leukocytes in Pleural fluid

2.28

1.03

1.6

1.2

0.8

4.7

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

1.74

1.03

1.1

1.0

—

(3007461) Platelets [#/volume] in Blood

1062

10489

1.31

1.00

43.5

18.7

e9/l

251.5

260.6

4.00

1052

10250

(3014051) Protein [Presence] in Urine by Test strip

223

1.40

0.99

2.7

2.1

—

(3022689) Creatine [Moles/volume] in Urine

2.18

0.98

4.0

1.5

—

(3002523) Influenza virus A Ag [Presence] in Specimen

173

1.46

0.98

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

173

1.46

0.98

1.1

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

190

1.43

0.97

6.3

3.6

mg/l

33.4

23.7

0.90

118

(3023511) Choriogonadotropin [Units/volume] in Urine

283

0.67

0.97

1.3

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

247

0.64

0.97

1.7

—

(3026361) Erythrocytes [#/volume] in Blood

1062

10495

1.30

0.93

43.5

18.7

e12/l

4.3

4.5

21.42

1049

10225

(3023323) Follitropin [Units/volume] in Serum or Plasma

636

1.23

0.93

1.4

iu/l

36.5

28.5

1.02

539

(3002256) Pathology report gross observation

136

1185

1.17

0.93

1.3

1.2

—

(40761511) CBC panel - Blood by Automated count

1005

9878

1.19

0.92

23.2

12.0

—

(3010813) Leukocytes [#/volume] in Blood

1062

10497

1.29

0.91

43.6

18.8

e9/l

6.3

6.6

3.51

1051

10227

(3000963) Hemoglobin [Mass/volume] in Blood

1062

10499

1.29

0.89

43.7

18.8

g/l

129.3

133.6

22.53

1057

10360

(3000012) Reticulocyte production index

1.91

0.88

2.5

1.6

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

549

1.23

0.88

1.9

1.4

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

701

0.80

0.86

1.2

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

1.57

0.84

1.1

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

502

1.23

0.79

5.6

8.7

mmol/l

24.4

24.7

0.39

471

(40765089) Chromosome analysis panel - Blood by G-banded

0.00

0.79

0.0

1.0

—

(3008898) HLA-B27 [Presence]

386

1.25

0.77

1.1

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

928

9098

1.12

0.74

4.7

4.3

mmol/l

5.6

5.8

8.76

870

8356

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

1.93

0.70

1.0

2.4

mg/l

7.7

10.1

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

101

1149

0.87

0.68

1.8

—

(3029396) Erythrocyte agglutination [Presence] in Blood

1.86

0.68

1.8

3.7

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

240

2221

1.10

0.67

1.7

1.4

—

(1761482) Bacteria [#/volume] in Urine by Culture

215

1.31

0.65

4.6

4.5

—

(3035637) Corticotropin [Mass/volume] in Plasma

112

1.43

0.63

1.3

1.6

—

(4146454)

1.52

0.62

4.1

2.7

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

199

0.70

0.62

1.2

1.1

u/ml

1.5

1.8

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.67

0.61

2.4

3.3

—

(3043410) Blood group antigens tested for on Red Blood Cells

1.67

0.61

2.0

1.3

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.67

0.61

2.4

3.3

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

959

9442

1.12

0.61

5.0

4.7

mmol/l

2.5

2.8

24.86

901

8756

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

421

0.80

0.60

1.6

1.7

mg/l

7.9

4.4

0.44

294

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

907

8910

1.10

0.58

4.2

3.8

mmol/l

1.2

1.3

0.42

850

8218

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

116

1041

1.13

0.57

4.0

4.6

ug/l

1.5

2.4

1.85

933

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

297

0.77

0.57

2.3

2.0

iu/l

11.7

4.7

—

110

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

1.67

0.56

3.8

2.4

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

205

0.73

0.54

1.1

1.5

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

1.49

0.53

1.1

1.3

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

1.54

0.53

1.5

1.3

—

(3019832) Treponema pallidum Ab [Presence] in Serum

121

1096

1.12

0.52

1.6

—

(4034850)

303

0.79

0.51

30.5

8.8

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

466

0.83

0.51

1.4

1.5

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

306

1.22

0.51

1.4

1.5

pmol/l

145.4

195.6

0.29

299

(3034274) Bile acid [Moles/volume] in Serum --fasting

136

1.33

0.49

2.1

2.5

umol/l

5.1

5.5

0.09

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

1.52

0.48

1.1

1.9

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

937

9244

1.09

0.46

4.7

4.2

mmol/l

1.5

0.65

882

8577

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

119

1090

1.10

0.44

5.9

6.2

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

1.41

0.43

2.3

1.2

—

(4198724)

1.62

0.43

1.0

1.5

—

(3028707) Methadone [Presence] in Urine by Screen method

158

1.27

0.42

1.7

1.4

—

(3003694) ABO and Rh group [Type] in Blood

277

2636

1.07

0.41

1.5

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

1.40

0.40

2.3

1.3

—

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

0.00

0.40

0.0

2.4

—

39.1

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

0.00

0.40

0.0

1.2

—

0.6

—

(44806420)

0.00

0.40

0.0

2.9

—

(3004451) EKG impression Narrative

1.43

0.39

1.6

1.3

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

940

9289

1.08

0.39

4.7

4.2

mmol/l

4.5

4.8

21.05

887

8659

(3036071) Salmonella sp Ab [Titer] in Serum

1.35

0.37

1.4

1.1

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

137

1276

1.08

0.37

1.7

2.1

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

169

0.77

0.37

1.2

1.1

u/ml

0.1

1.7

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

1.40

0.35

2.7

2.2

ug/l

24.5

20.3

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

222

0.81

0.35

3.6

3.8

u/ml

32.2

32.5

0.01

216

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

605

1.11

0.34

1.6

1.7

—

(3005570) Glucose [Moles/volume] in Urine

100

1.30

0.33

2.2

2.5

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

1.28

0.32

3.7

3.1

—

(3009542) Hematocrit [Volume Fraction] of Blood

882

8715

1.06

0.31

29.5

13.5

37.9

39.5

5.67

644

6499

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

1.30

0.30

1.4

1.3

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

166

1.21

0.30

1.3

1.2

—

(40768793) Breast Pathology biopsy report

313

0.86

0.29

1.4

1.3

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

353

0.87

0.27

2.0

1.8

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

0.00

0.21

0.0

1.4

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

0.00

0.21

0.0

6.5

—

(3015616) Isopropanol [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

1.7

—

(3008402) Methanol [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

1.5

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

2.6

—

38.8

—

(3020393) Adenovirus Ag [Presence] in Stool

0.00

0.21

0.0

1.0

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

469

1.09

0.21

1.7

1.4

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

0.00

0.21

0.0

1.3

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

1.16

0.21

1.2

1.5

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

177

0.85

0.21

1.2

1.1

u/ml

7.3

3.8

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

155

0.84

0.20

1.3

1.7

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

1.18

0.19

1.0

1.2

u/l

436.0

459.6

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

1.21

0.18

1.3

1.4

mmol/l

5.4

6.0

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

1.13

0.17

1.1

—

(3020891) Body temperature

320

1.10

0.17

3.5

4.3

—

(1617658) Protocol used for examination of sentinel lymph nodes

110

1.18

0.17

1.1

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

1.18

0.16

1.0

1.4

ug/l

4.2

5.9

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

1.13

0.16

1.3

1.5

g/l

1.0

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

351

1.09

0.15

1.4

1.6

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

102

1.18

0.15

3.7

2.5

—

(44813793)

1.13

0.15

1.0

1.1

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

605

1.06

0.15

2.5

2.8

ug/l

0.8

0.7

0.12

392

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

0.79

0.14

1.7

mmol/l

6.9

7.7

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

189

1.11

0.13

1.9

2.0

nmol/l

1.0

0.9

0.18

154

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

128

0.86

0.13

1.2

1.1

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

119

1149

1.04

0.13

1.7

2.0

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

836

1.04

0.12

3.2

4.1

22.7

21.4

0.30

384

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

191

1.10

0.11

1.4

1.6

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

270

1.08

0.10

1.6

1.4

—

(3006653) Thiamine [Moles/volume] in Blood

1.06

0.09

1.2

1.6

nmol/l

119.8

145.6

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

468

1.05

0.09

1.8

2.1

u/l

7538.0

4195.2

0.19

199

(3015183) Erythrocyte sedimentation rate

1.07

0.08

1.2

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

0.83

0.08

1.0

1.1

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

0.79

0.08

3.4

6.7

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

0.77

0.08

1.0

1.6

promille

0.8

1.2

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

1.09

0.08

1.3

1.9

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

1.06

0.08

1.1

1.2

—

(4281824)

121

0.91

0.06

1.5

1.1

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

107

1057

1.01

0.03

1.6

1.4

—

(3000764) Benzodiazepines [Presence] in Urine

352

1.02

0.01

1.6

1.4

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

122

0.98

0.00

1.2

—

(1002224) Polysomnography panel

418

1.00

0.00

1.1

—

(3011288) Drugs identified in Urine by Screen method

229

1.00

0.00

2.1

1.6

—

(3016879) Cocaine [Presence] in Urine

329

1.00

0.00

1.6

1.4

—

(3027944) Amphetamines [Presence] in Urine

347

1.01

0.00

1.6

1.4

—

(3027008) Opiates [Presence] in Urine

353

0.99

0.00

1.6

1.4

—

(3028300) Cannabinoids [Presence] in Urine

355

1.01

0.00

1.6

1.4

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

785

1.01

0.00

1.7

1.8

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

0.91

0.00

1.6

1.3

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

0.00

0.0

1.0

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.00

0.0

1.2

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

0.0

1.0

—

(3043681) Transitional cells [#/area] in Urine by Computer assisted method

0.00

0.0

1.2

—

1.0

—

(3010838) Calcium [Moles/time] in 24 hour Urine

0.97

0.00

1.2

1.5

—

8.3

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.00

0.0

1.7

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

0.00

0.0

1.0

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

0.00

0.0

1.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

0.0

1.0

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

0.00

0.0

1.0

—

(3039443) Prostate specific Ag panel - Serum or Plasma

0.96

0.00

1.0

1.5

—

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

0.00

0.0

1.0

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

0.94

0.00

1.4

1.2

—

(3018081) Beta-2-Microglobulin [Mass/volume] in Urine

0.00

0.0

1.8

—

9.3

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

0.0

2.0

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

0.00

0.0

1.0

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

0.00

0.0

1.0

—

(3006270) Folate [Moles/volume] in Blood

0.92

0.00

1.6

1.1

nmol/l

334.1

403.7

—

(3023436) Glucagon [Mass/volume] in Serum or Plasma

0.00

0.0

2.0

—

181.9

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

0.0

2.0

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

0.00

0.0

1.7

—

330.7

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

0.0

2.0

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

0.00

0.0

6.8

—

(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma

0.00

0.0

1.0

—

1.9

—

(3011048) Pyruvate [Moles/volume] in Blood

0.00

0.0

1.3

—

87.4

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

0.0

1.0

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: SLE_NOS – Systemic lupus erythematosus, unspecified

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Systemic lupus erythematosus, unspecified

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Systemic lupus erythematosus, unspecified (SLE_NOS)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints